GREY WOLFNPV |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.78 CAD | +4.00% |
|
+8.33% | +5.41% |
| 04-11 | Grey Wolf Animal Health Swings to a Q4 Loss Despite Revenue Gain | MT |
| 04-11 | Grey Wolf Animal Health Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2022 | 22.64M 16.49M | Sales 2023 | 25.41M 18.51M | Capitalization | 22.96M 16.73M |
|---|---|---|---|---|---|
| Net income 2022 | 2M 1.46M | Net income 2023 | - 0 | EV / Sales 2022 | 1.25 x |
| Net Debt 2022 | 4.17M 3.04M | Net Debt 2023 | 2.14M 1.56M | EV / Sales 2023 | 0.99 x |
| P/E ratio 2022 |
5.12
x | P/E ratio 2023 |
37.7
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 85.88% |
More Fundamentals
* Assessed data
| 1 week | +8.33% | ||
| Current month | -11.36% | ||
| 1 month | -11.36% | ||
| 3 months | -17.02% | ||
| 6 months | +6.85% | ||
| Current year | +5.41% |
1 week
0.73
0.80
1 month
0.690.86
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-29 | 0.78 | +4.00% | 1,267 |
| 24-04-26 | 0.75 | +2.74% | 220,421 |
| 24-04-25 | 0.73 | -8.75% | 15,500 |
| 24-04-24 | 0.8 | +11.11% | 1,010 |
| 24-04-22 | 0.72 | -1.37% | 5,100 |
Delayed Quote Toronto S.E., April 29, 2024 at 09:30 am
More quotes
Grey Wolf Animal Health Corp. is a Canada-based animal health and wellness company. It has a portfolio of products that meets the unmet needs of veterinarians, clinics, and pets. Its segments include the animal health business unit and the pharmacy business unit. The animal health business unit segment primarily focuses on selling, marketing, and distributing pharmaceutical, nutraceutical and consumable products to veterinary clinics across Canada. The pharmacy business unit segment compounds pharmaceuticals, primarily for equine use but also for the bioidentical hormone replacement therapy market, all based on prescriptions received from veterinarians, physicians, and patients. Its product categories include companion animals and equine health. The companion animals product category includes wound care, nutraceuticals, and others. It focuses on in-licensing, acquiring, or developing prescription and non-prescription products for commercialization in the veterinarian channel in Canada.
Sector
Other Specialty Retailers
| 1st Jan change | Capi. | |
|---|---|---|
| -33.26% | 6.86B | |
| +15.74% | 1.92B | |
| +9.59% | 1.65B | |
| -4.29% | 902M | |
| +20.76% | 426M | |
| -50.63% | 421M | |
| -11.82% | 325M | |
| +36.56% | 195M | |
| -3.09% | 99.79M |
- Stock Market
- Equities
- WOLF Stock
- WOLF Stock
